Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection

AIDS

Volumn 11, Issue 3, 1997, Pages 311-317

  Chaisson, Richard E ^a,h   Keiser, Philip ^b   Pierce, Mark ^c   Fessel, W Jeffrey ^d   Ruskin, Joel ^d   Lahart, Christopher ^e   Benson, Constance A ^f   Meek, Kysa ^g   Siepman, Nancy ^g   Craft, J Carl ^g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

^e MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f RUSH MEDICAL COLLEGE   (United States)

^g ABBOTT LABORATORIES   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Clarithromycin; Clinical trials; Clofazimine; Ethambutol; HIV; Mycobacterium avium complex; Survival

Indexed keywords

CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL; MACROLIDE; TUBERCULOSTATIC AGENT;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTEREMIA; BACTERIAL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; CLARITHROMYCIN; CLOFAZIMINE; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; HUMANS; MALE; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION;

EID: 0012070601     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199703110-00008     Document Type: Article

References (28)

1. Horsburgh Jr C R: Mycobacterium avium-complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991, 324:1332 1338.
2. Hoover DR, Saah AJ, Bacellar H, et al.: Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med 1993, 329:1922 1926.
3. Chaisson RE, kerulv J, Richman DD, Moore RD: Incidence and natural history of Mycobacterium avium-complex disease in advanced HIV infection treated with Zidovudine. Am Rev Respir Dis 1992, 146:285 289.
4. Chin DP, Hopewell PC, Yajko DM, et al.: Mycobacterium avium-complex in the respiratory or gastrointestinal tract and the risk of M. avium-complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis 1994, 169:289 295.
5. US Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex: Recommendations on prophylaxis and therapy for disseminated Mycohaclerium avium complex for adults and adolescents infected with human immunodeficiency virus. MMWR 1993, 42 (RR-9):14 20.
6. Dautzenberg B, Trutfot C, Legris S, et al.: Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. Am Rev Respir Dis 1991, 144:564 569.
7. Chaisson RL, Benson CA, Dube MP, et al.: Clarithromycin therapy for bacteremic Mycobacterium avium complex disease: a randomized, double-blind, dose-ranging study in patients with AIDS. Ann Intern Med 1994, 121:905 911.
8. Wallace RJ, Brown BA, Griffith DE, et al.: Initial clarithromycin monotherapy for Mycobacterial avium-intracellulare complex lung disease. Am Rev Respir Dis 1994, 149:1335 1341.
9. Chin DP, Hopewell PC: How to treat bacteremic Mycobacterium avium complex disease. Lancet 1995, 346:920 921.
10. Kemper CA, Havlir D, Haghighat D, et al.: The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS. J Infect Dis 1994, 170:157 164.
11. Kemper CA, Meng I-C, Nussbaum J, et al.: Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen: rifampin, ethambutol, clofazimine, and ciprofloxacin. Ann Intern Med 1992, 116:466-472.
12. Heifets LB, Lindholm-Levy PJ, Comstock RD: Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. Am Rev Respir Dis 1992, 145:856 858.
13. Dautzenberg B, Saint Marc L, Meyohas MC, et al.: Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquire immunodeficiency syndrome. Arch Intern Med 1993, 153:368-372.
14. Pierce M, Lamarca A, Jablonowski H, et al.: A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 1996, 335:384 391.
15. Centers for Disease Control and Prevention: USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR 1995, 44 (RR-8):1 34.
16. Masur H, Luazon C, Gill V, et al.: Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. J Infect Dis 1987, 155:127 129.
17. Agins BD, Berman DS, Spicehandlear D, et al.: Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in AIDS. J Infect Dis 1989, 159:784-787.
18. Bermudez H, Young LS: Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. Antimicrob Agents Chemother 1988, 32:1149 1153.
19. Chiu J, Nussbaum J, Bozzette S, et al.: Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann Intern Med 1990, 113:358 361.
20. May L, Brel F, Beuscart C, et al.: French randomized open trial of two clarithromycin combination therapies for Mycobacterium avium complex bacteremia: first results. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, September 1995 [abstract 1B-19].
21. Dube M, Sattler F, Iorriani F, et al.: Prevention of relapse of MAC bacteremia in AIDS: a randomized study of clarithromycin plus clofazimine, with or without ethambutol. Third Conference on Retroviruses and Opportunistic Infections. Washington, DC, January February 1996 [abstract 206].
22. Horsburgh CR, Metchock B, Gordon SM, et al.: Predictors of survival in patients with AIDS and disseminated Mycobacterium avium complex disease. J Infect Dis 1994, 170:573 577.
23. Kemper CA, Havlir D, Bartok AF, et al.: Transient bacteremia due to Mycobacterium avium complex in patients with AIDS. J Infect Dis 1994, 170:488 493.
24. Havlir DV, McCutchan JA, Bozzette SA, et al.: A double-blind randomized study of weekly azithromycin, daily rifabutin, and combination azithromycin and rifabutin for the prevention of Mycobacterium avium complex in AIDS patients. N Engl J Med 1996, 335:392 398.
25. Nightingale SD, Cameron DW, Gordin FM, et al.: Two controlled trials of rifabutin prophylaxis against Mycobacterium avium-complex infection in AIDS. N Engl Med 1993, 329: 828 833.
26. Moore RD, Chaisson RE: The natural history of opportunistic disease in an urban HIV clinical cohort. Ann Intern Med 1996, 124:633 642.
27. Hoy J, Mijch A, Sandland M, et al.: Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. J Infect Dis 1990, 161:801 805.
28. Shatran S, Singer J, Phillips P, et al.: Canadian randomized openlabel trial of combination therapy for Mycobacterium avium complex bacteremia: final results. N Engl Med 1996, 335:377 383.